PPQ-102
|
|
- CAS番號(hào).
- 931706-15-9
- 化學(xué)名:
- 別名:
- 英語名:
- PPQ-102
- 英語別名:
- PPQ-102;CS-1365;CFTR Inhibitor;PPQ 102, >=98%;PPQ-102, CFTR Inhibitor;CFTR INHIBITOR; PPQ102; PPQ 102;CFTR Inhibitor IV, PPQ-102 - CAS 931706-15-9 - Calbiochem;7,9-Dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-5,6-dihydropyrimido[4',5':3,4]pyrrolo[1,2-a]quin;6,7-Dihydro-7,9-dimethyl-6-(5-methyl-2-furanyl)-11-phenylpyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9)-dione;7,9-DIMETHYL-6-(5-METHYL-2-FURYL)-11-PHENYL-6,7-DIHYDROPYRIMIDO[4 ',5':3,4]PYRROLO[1,2-A]QUINOXALINE-8,10(5H,9H)-DIONE
- CBNumber:
- CB82628279
- 化學(xué)式:
- C26H22N4O3
- 分子量:
- 438.48
- MOL File:
- 931706-15-9.mol
- MSDS File:
- SDS
|
PPQ-102 物理性質(zhì)
- 融點(diǎn) :
- >300℃ (ethanol )
- 沸點(diǎn) :
- 648.7±65.0 °C(Predicted)
- 比重(密度) :
- 1.39±0.1 g/cm3(Predicted)
- 貯蔵溫度 :
- -20C
- 溶解性:
- DMF: 0.2 mg/ml
- 外見 :
- 白色結(jié)晶性固體
- 酸解離定數(shù)(Pka):
- 1.00±0.40(Predicted)
- 色:
- Light yellow to yellow
安全性情報(bào)
- リスクと安全性に関する聲明
- 危険有害性情報(bào)のコード(GHS)
絵表示(GHS) |
|
注意喚起語 |
警告 |
危険有害性情報(bào) |
コード |
危険有害性情報(bào) |
危険有害性クラス |
區(qū)分 |
注意喚起語 |
シンボル |
P コード |
H302 |
飲み込むと有害 |
急性毒性、経口 |
4 |
警告 |
|
P264, P270, P301+P312, P330, P501 |
H317 |
アレルギー性皮膚反応を起こすおそれ |
感作性、皮膚 |
1 |
警告 |
|
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
|
注意書き |
P280 |
保護(hù)手袋/保護(hù)衣/保護(hù)眼鏡/保護(hù)面を著用するこ と。 |
P305+P351+P338 |
眼に入った場合:水で數(shù)分間注意深く洗うこと。次にコ ンタクトレンズを著用していて容易に外せる場合は外す こと。その後も洗浄を続けること。 |
|
メーカー |
製品番號(hào) |
製品説明 |
CAS番號(hào) |
包裝 |
価格 |
更新時(shí)間 |
購入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01COBQJ-2415 |
Ppq-102 |
931706-15-9 |
250mg |
¥165000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01COBQJ-2415 |
Ppq-102 |
931706-15-9 |
1g |
¥440000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01CAY16275 |
PPQ-102 |
931706-15-9 |
5mg |
¥25200 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01CAY16275 |
PPQ-102 |
931706-15-9 |
10mg |
¥47900 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TOC4303 |
PPQ 102 |
931706-15-9 |
10mg |
¥61000 |
2024-03-01 |
購入 |
PPQ-102 化學(xué)特性,用途語,生産方法
一般的な説明
A cell-permeable pyrimido-pyrrolo-quinoxalinedione (PPQ) compound that targets the intracellular nucleotide binding domain(s) of CFTR and inhibits CFTR-mediated chloride current in a reversible and voltage-independent manner. Single channel recordings of CFTR-expressing FRT cells upon forskolin (Cat. No. 344270) and IBMX (Cat. No. 410957) stimulation indicate that the nature of PPQ-102 inhibition is due to a stabilization of the channels in a closed state (7.8- vs. 0.4-fold increase of mean channel close vs. open time, respectively, with 1 μM PPQ-102). PPQ-102 at 5 μM is shown to completely prevent Sp-8-Br-cAMP- (Cat. No. 116818) induced cysts formation and reduce the size of preformed cysts in an
ex vivo murine neonatal kidney organ culture.
PPQ-102 上流と下流の製品情報(bào)
原材料
準(zhǔn)備製品
PPQ-102 生産企業(yè)
Global( 77)Suppliers
931706-15-9()キーワード:
- 931706-15-9
- PPQ-102
- 7,9-DIMETHYL-6-(5-METHYL-2-FURYL)-11-PHENYL-6,7-DIHYDROPYRIMIDO[4 ',5':3,4]PYRROLO[1,2-A]QUINOXALINE-8,10(5H,9H)-DIONE
- PPQ-102, CFTR Inhibitor
- 6,7-Dihydro-7,9-dimethyl-6-(5-methyl-2-furanyl)-11-phenylpyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9)-dione
- 7,9-Dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-5,6-dihydropyrimido[4',5':3,4]pyrrolo[1,2-a]quin
- 6,7-Dihydro-7,9-dimethyl-6-(5-methyl-2-furanyl)-11-phenylpyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9)-dione PPQ-102
- PPQ-102 6,7-Dihydro-7,9-dimethyl-6-(5-methyl-2-furanyl)-11-phenylpyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9)-dione
- PPQ 102, >=98%
- CS-1365
- CFTR Inhibitor
- CFTR INHIBITOR; PPQ102; PPQ 102
- CFTR Inhibitor IV, PPQ-102 - CAS 931706-15-9 - Calbiochem
- Pyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9)-dione, 6,7-dihydro-7,9-dimethyl-6-(5-methyl-2-furanyl)-11-phenyl-
- 7,9-Dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-6,7-dihydropyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9H)-dione
- polycystic kidney disease,E13.5 embryonic kidneys,inhibit,Inhibitor,PPQ-102,CFTR,Cystic fibrosis transmembrane conductance regulator
- 7,9-Dimethyl-6-(5-methylfuran-2-yl)-11-phenyl-6,7-dihydropyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9H)-dione